Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.475 USD | +0.27% | +1.67% | -39.15% |
Jun. 05 | Aurinia Pharmaceuticals Inc. Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis | CI |
Jun. 03 | Lucien Selce Sends Letter to Aurinia shareholders | CI |